Sysmex Co. (OTCMKTS:SSMXY) Short Interest Update

Sysmex Co. (OTCMKTS:SSMXY) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 369,500 shares, an increase of 627.4% from the August 31st total of 50,800 shares. Based on an average daily volume of 765,400 shares, the days-to-cover ratio is presently 0.5 days.

Sysmex Trading Down 1.9 %

SSMXY stock traded down $0.37 during trading on Wednesday, reaching $19.16. The company had a trading volume of 27,799 shares, compared to its average volume of 116,646. The business has a 50 day moving average of $18.14 and a 200 day moving average of $17.19. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.23 and a quick ratio of 2.40. The company has a market cap of $12.06 billion, a P/E ratio of 37.82 and a beta of 0.84. Sysmex has a 52 week low of $14.38 and a 52 week high of $29.78.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.11 earnings per share for the quarter. The company had revenue of $718.13 million for the quarter. Sysmex had a return on equity of 11.15% and a net margin of 10.25%. As a group, sell-side analysts forecast that Sysmex will post 0.65 earnings per share for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.